rosiglitazone has been researched along with formazans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fackett, A; Hayden, MJ; Hewitt, NJ; Li, AP; Lloyd, S; Sakai, Y; Silber, PM | 1 |
| Ahn, JH; Cheon, HG; Kim, KY | 1 |
2 other study(ies) available for rosiglitazone and formazans
| Article | Year |
|---|---|
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors.
Topics: Adenosine Triphosphate; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Chemical and Drug Induced Liver Injury; Chromans; Coloring Agents; Female; Formazans; Glutathione; Hepatocytes; Humans; Hypoglycemic Agents; Infant; Liver Diseases; Male; Middle Aged; Neutral Red; Oxazines; Rosiglitazone; Sex Factors; Smoking; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Troglitazone; Xanthenes | 2002 |
Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Topics: Apoptosis; Benzhydryl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Epoxy Compounds; Formazans; Humans; Indenes; Lung Neoplasms; Morpholines; PPAR gamma; Proline Oxidase; Reactive Oxygen Species; RNA Interference; Rosiglitazone; Tetrazolium Salts; Thiazolidinediones | 2007 |